These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 21195731)

  • 1. The use of soluble African horse sickness viral protein 7 as an antigen delivery and presentation system.
    Rutkowska DA; Meyer QC; Maree F; Vosloo W; Fick W; Huismans H
    Virus Res; 2011 Mar; 156(1-2):35-48. PubMed ID: 21195731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of recombinant African horse sickness virus VP7 antigen via a simple method and validation of a VP7-based indirect ELISA for the detection of group-specific IgG antibodies in horse sera.
    Maree S; Paweska JT
    J Virol Methods; 2005 Apr; 125(1):55-65. PubMed ID: 15737417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of domain-switching and site-directed mutagenesis on the properties and functions of the VP7 proteins of two orbiviruses.
    Monastyrskaya K; Staeuber N; Sutton G; Roy P
    Virology; 1997 Oct; 237(2):217-27. PubMed ID: 9356334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Dual Laser Scanning Confocal and Transmission Electron Microscopy Analysis of the Intracellular Localization, Aggregation and Particle Formation of African Horse Sickness Virus Major Core Protein VP7.
    Wall GV; Rutkowska DA; Mizrachi E; Huismans H; van Staden V
    Microsc Microanal; 2017 Feb; 23(1):56-68. PubMed ID: 28112080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the three-dimensional structure of the African horse sickness virus VP7 trimer by homology modelling.
    Bekker S; Burger P; van Staden V
    Virus Res; 2017 Mar; 232():80-95. PubMed ID: 28167267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. African horsesickness virus VP7 sub-unit vaccine protects mice against a lethal, heterologous serotype challenge.
    Wade-Evans AM; Pullen L; Hamblin C; O'Hara R; Burroughs JN; Mertens PP
    J Gen Virol; 1997 Jul; 78 ( Pt 7)():1611-6. PubMed ID: 9225037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of bluetongue virus chimeric VP3 molecules and their interactions with VP7 protein to assemble into virus core-like particles.
    Tanaka S; Mikhailov M; Roy P
    Virology; 1995 Dec; 214(2):593-601. PubMed ID: 8553561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of immunogenic virus-like particles by inserting epitopes into surface-exposed regions of hamster polyomavirus major capsid protein.
    Gedvilaite A; Frömmel C; Sasnauskas K; Micheel B; Ozel M; Behrsing O; Staniulis J; Jandrig B; Scherneck S; Ulrich R
    Virology; 2000 Jul; 273(1):21-35. PubMed ID: 10891404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of a Soluble African Horse Sickness Virus VP7 Protein Capable of Forming Core-like Particles.
    Bekker S; Huismans H; van Staden V
    Viruses; 2022 Jul; 14(8):. PubMed ID: 35893692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the major core antigen VP7 of African horsesickness virus by a recombinant baculovirus and its use as a group-specific diagnostic reagent.
    Chuma T; Le Blois H; Sánchez-Vizcaíno JM; Diaz-Laviada M; Roy P
    J Gen Virol; 1992 Apr; 73 ( Pt 4)():925-31. PubMed ID: 1378881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a linear neutralization domain in the protein VP2 of African horse sickness virus.
    Martínez-Torrecuadrada JL; Casal JI
    Virology; 1995 Jul; 210(2):391-9. PubMed ID: 7542417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. African horse sickness virus serotype 4 antigens, VP1-1, VP2-2, VP4, VP7 and NS3, induce cytotoxic T cell responses in vitro.
    Faber FE; van Kleef M; Tshilwane SI; Pretorius A
    Virus Res; 2016 Jul; 220():12-20. PubMed ID: 27063332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
    Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
    Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minor displacements in the insertion site provoke major differences in the induction of antibody responses by chimeric parvovirus-like particles.
    Rueda P; Hurtado A; del Barrio M; Martínez-Torrecuadrada JL; Kamstrup S; Leclerc C; Casal JI
    Virology; 1999 Oct; 263(1):89-99. PubMed ID: 10544085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein aggregation complicates the development of baculovirus-expressed African horsesickness virus serotype 5 VP2 subunit vaccines.
    du Plessis M; Cloete M; Aitchison H; Van Dijk AA
    Onderstepoort J Vet Res; 1998 Dec; 65(4):321-9. PubMed ID: 10192846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular production of African horsesickness virus core-like particles by expression of the two major core proteins, VP3 and VP7, in insect cells.
    Maree S; Durbach S; Huismans H
    J Gen Virol; 1998 Feb; 79 ( Pt 2)():333-7. PubMed ID: 9472617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of a recombinant fusion protein of tandem repeat epitopes of foot-and-mouth disease virus type Asia 1 for guinea pigs.
    Zhang Q; Yang YQ; Zhang ZY; Li L; Yan WY; Jiang WJ; Xin AG; Lei CX; Zheng ZX
    Acta Virol; 2002; 46(1):1-9. PubMed ID: 12199204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of competitive ELISA for serodiagnosis on African horsesickness virus using baculovirus expressed VP7 and monoclonal antibody.
    Kweon CH; Kwon BJ; Ko YJ; Kenichi S
    J Virol Methods; 2003 Oct; 113(1):13-8. PubMed ID: 14500122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of immune responses against foot-and-mouth disease virus induced by fusion proteins using the swine IgG heavy chain constant region or beta-galactosidase as a carrier of immunogenic epitopes.
    Li G; Chen W; Yan W; Zhao K; Liu M; Zhang J; Fei L; Xu Q; Sheng Z; Lu Y; Zheng Z
    Virology; 2004 Oct; 328(2):274-81. PubMed ID: 15464847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VP7 from African horse sickness virus serotype 9 protects mice against a lethal, heterologous serotype challenge.
    Wade-Evans AM; Pullen L; Hamblin C; O'Hara RS; Burroughs JN; Mertens PP
    Arch Virol Suppl; 1998; 14():211-9. PubMed ID: 9785508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.